INGEN HOUSZ

SC Ventures by Standard Chartered, Standard Chartered’s innovation, fintech investment and ventures arm, has made a strategic investment in One Trading, a European crypto-asset exchange. As part of this round, existing investor MiddleGame Ventures increased its stake in One Trading, while Valar Ventures LLC and Speedinvest also participated. “We welcome SC Ventures as an investor in the company and believe they can add a lot of value to One Trading and our clients,” said Joshua Barraclough, Founder and CEO of One Trading. One Trading will use the investment to support launching the first crypto perpetual futures in the European Union (EU) as a MiFID II trading venue. The MiFID II is a regulatory framework the EU rolled out in 2018 to increase transparency and improve investor protections across European financial markets. In July 2024, the Dutch financial market regulator granted One Trading an Organised Trading Facility (OTF) License, which establishes One Trading as a MiFID II trading venue. With the OTF License approval, One Trading is the only crypto perpetual futures trading venue in the EU and the first cash-settled perpetuals platform in Europe, including the UK. One Trading is also the first regulated derivatives exchange in Europe which will be accessible to retail clients. “We saw the potential for One Trading early in its journey and we are delighted to be participating with SC Ventures and others in this investment. We are happy to support One Trading to become the undisputed leading onshore, licensed and institutional trading venue the digital assets market has been clamouring for,” said 🏉 Pascal Bouvier, Managing Partner, MiddleGame Ventures. INGEN HOUSZ (Joep Wolfhagen) advised MiddleGame Ventures.

Proud that for the second year in a row Mergermarket has shortlisted us for the European M&A Awards, category Benelux Legal Advisor of the Year. INGEN HOUSZ, shaping the new economy.

INGEN HOUSZ advised scaleups and investors on 66 large investment rounds - transactions with amount invested >€25 Million - for a total amount of €4.48 Billion. Source: dealmaker.nl INGEN HOUSZ, shaping the new economy.

Holland Capital invests in Blyott, which offers real-time solutions for tracing medical equipment within healthcare institutions. Blyott develops tags that show the location of medical devices in healthcare facilities in real time. In addition to location determination, the tags, by using AI, also provide insight into other aspects such as the use of the equipment. Gery Pollet, Founder & CEO Blyott: “I look forward to working with Holland Capital given their experience and investments with a focus on healthcare. Holland Capital is the right partner to accelerate our international growth.” Sterre Witteveen, Investment Manager Holland Capital: “We are constantly looking for cost-efficient innovations that have an impact in healthcare. With Blyott's platform, not only precious time is freed up for healthcare staff. It is also possible to save on unnecessary purchase of medical equipment. We look forward to rolling out Blyott worldwide together with the experienced management team.“ INGEN HOUSZ (Meelf van Oosten, Selene Snippe, Frans Ruijs) advised Holland Capital.

NOVAMEAT has raised €17.4 million in an oversubscribed Series A round. The investment was led by Sofinnova Partners and Forbion and follows a reinvestment from Unovis Asset Management, Praesidium and Rubio Impact Ventures. "Novameat has the potential to revolutionise the food industry by providing sustainable and tasty alternatives to animal-based proteins," said Joško Bobanović, Partner at Sofinnova Partners. Alexander Hoffmann, General Partner for Forbion’s BioEconomy Fund, added, "Novameat’s proprietary technology is truly groundbreaking. We are excited to work with Novameat as they continue to push the boundaries in plant-based foods and contribute to solving critical global sustainability issues." INGEN HOUSZ (Quirijn van Veen) advised Rubio Impact Ventures.

Battolyser Systems has raised €30 million in Series A funding from Global Cleantech Capital, Innovation Industries, and Invest-NL. Battolyser Systems is the manufacturer of the world’s only electrolyser with battery functionality. The Battolyser® technology can switch on and off following intermittent renewable energy. With its 100% flexibility, it unlocks new business models, reducing the cost of green hydrogen and alleviating grid congestion. Mattijs Slee, CEO of Battolyser Systems said: “Over the last year we scaled our technology from a successful industrial pilot at RWE’s Magnum power plant in Eemshaven, The Netherlands, to a MW-scale demonstration unit. We are proud to receive the continuous support of our existing investors with deep and cleantech expertise whilst adding Invest-NL, which plays a crucial role in the Dutch energy transition." The Series A funding complements the €40 million financing agreement signed with the European Investment Bank (EIB) in October 2023. Battolyser Systems was the first Dutch climate tech scale- up investment of the EIB. The Series A and EIB funding will significantly contribute to the financing of Battolyser Systems’ large-scale manufacturing facility to meet commercial demand, and will be located in the Rotterdam port area, the hydrogen epicentre of Europe. INGEN HOUSZ (Matthijs Ingen-Housz, Daan Gieben) advised Battolyser Systems, both on the EIB Financing and on the Series A round.

SOLASTA Bio attracts a $14 million Series A investment. This new round was led by Forbion and joined by new investors including FMC Corporation and Corteva Agriscience. Additionally, extra support came from existing investors Cavallo Ventures, Scottish Enterprise, SIS Ventures and Rubio Impact Ventures. With this funding the company can expand their pioneering work in sustainable biopesticides, towards a more sustainable and resilient agricultural sector where we foster biodiversity. INGEN HOUSZ (Quirijn van Veen) advised Rubio Impact Ventures.

819 Capital Partners leads an investment round in Vidiia Ltd., investing alongside a bio-scientist entrepreneur and a few other investors. Vidiia commercialises a fast and accurate molecular diagnostic testing platform with built-in Artificial Intelligence. Sven Kempers, director at 819 Capital Partners, expresses trust in Vidiia’s platform and team: “Vidiia’s technology provides many testing options for rapid diagnoses. We are confident that the team will successfully execute the growth strategy.” Professor Roberto La Ragione – Professor of Veterinary Microbiology and Pathology – said: “Infectious diseases remain a global threat to human and animal health, and our economies. Funding is necessary to enable Vidiia and our scientists to continue our work in developing highly accurate and rapid tests to prevent the next pandemic.” INGEN HOUSZ (Quirijn van Veen, Matthijs Ingen-Housz) advised 819 Capital Partners

L2L, the global leader in connected workforce solutions, announced the acquisition of SwipeGuide, a European trailblazer in mobile-first frontline training and visual job aids for the manufacturing workforce. SwipeGuide enhances L2L's training and skills management capabilities, offering an intuitive solution for capturing and distributing critical operational knowledge on the factory floor in a collaborative way. Established in 2016 over a mutual frustration with traditional paper instructions, Daan Assen and Willemijn Schneyder founded SwipeGuide to change the way we work and learn in a manufacturing environment. Currently around 300,000 users in over 90 countries use SwipeGuide's solution on a daily basis. INGEN HOUSZ (Matthijs Ingen-Housz, Berend Veenstra) advised SwipeGuide and its sellers.

Carbyon closed a Series A investment round of €15.3 million. This will allow Carbyon to demonstrate its Direct Air Capture technology at full scale. Siemens Financial Services, Omnes and Global Cleantech Capital joined as new investors alongside Invest-NL, Lowercarbon Capital, Brabantse Ontwikkelings Maatschappij (BOM) and Innovation Industries. Founder CEO Hans De Neve said: "This consortium is a dream scenario and is highly motivating to continue with our mission. We are incredibly grateful for the trust and support of our investors!" Carbyon is a TNO spinoff based in High Tech Campus Eindhoven. Carbyon scientists and engineers are on a mission to tackle climate change through direct air capture (DAC). It is developing DAC-machines using a patented ultra-fast capturing technique. INGEN HOUSZ (Matthijs Ingen-Housz, Berend Veenstra) advised Carbyon